The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist
about
The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteersThe cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effectsIschaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol.Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillationEffects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricleOral xamoterol in patients with sinoatrial disease.Preliminary study of the efficacy of xamoterol in bradycardia-tachycardia syndrome.Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failureThe pharmacokinetics of xamoterol in liver disease.Relationship between positive inotropic responses and plasma concentrations of xamoterol in middle-aged and elderly patients.The lipolytic effect of beta 1- and beta 2-adrenoceptor activation in healthy human volunteersThe effects and dose-response relationship of xamoterol in patients with ischaemic heart diseaseBeta-adrenoceptor antagonists increase sinus arrhythmia, a vagotonic effect.Effects of xamoterol (ICI 118,587) in asthmatic patients.Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failureThe in vitro pharmacology of xamoterol (ICI 118,587).Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: studies of function and regulation.Some aspects of heart beta adrenoceptor function.Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunctionBeta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapyThe pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.Comparative effects of beta-adrenoceptor partial agonists on isolated rat atrium.Modulation of the autonomic control of the failing heart.Haemodynamic effects of ICI 118,587 in cardiomyopathy.Beta-adrenoceptor subtype expression and function in rat white adipocytes.The effects of ICI 118,587 and atenolol on the responses to exercise and on breathlessness in healthy subjects.A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.Pharmacokinetics of xamoterol glucuronidation in the rat in vivo and in liver perfusion.Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.The effect of oral dosing of xamoterol on systolic time intervals in man and xamoterol plasma concentrations in heart failure patients.POSTER COMMUNICATIONS
P2860
Q24540455-918FD86C-82A5-4AAF-85E5-328B3B916578Q28257885-24C02FAE-78AA-470B-9B65-A66C82BF1756Q28343197-266D9C37-C755-4DA0-8B68-825E54F68F31Q28359279-B7806196-5D60-4A2D-A417-D3F8FD58816DQ33610465-A2EF0D05-C453-4519-828B-CA8C021D5A0BQ33610619-7C879CB1-9275-4014-8FA1-790FF0A7CD54Q34016593-00271777-7F62-4552-B9D0-B343747FD18EQ34049087-728E227A-70CA-4E9E-9523-A26064534DA9Q34346336-39745C16-B5C7-41A0-99F6-3D0F48C2F22FQ34397513-4C4113C3-928E-4B14-9A32-7145E6B942DCQ34398082-3163FE52-EDD0-4841-8EAE-8F6406E5D686Q34398404-17665F1F-55C7-43ED-8195-ECB5A37971E3Q34403478-0ED5362A-B08C-41F1-92D0-9430094B8EDEQ34416839-BFCB37A6-D51E-4F9C-A7C9-75CC5B8F23E1Q34448241-387767D9-6124-4AC2-B5AD-DACBE64665E8Q34621888-FA1CA9E9-6481-4095-BD7F-4149786DFD1BQ34622032-036BE18D-5F50-42A0-999D-531EAA045280Q34872068-CDCFEFAC-5AEA-4271-A59E-B3A0473F0E24Q35886759-CB01042A-C39E-4B04-B353-1FC68605FEF7Q35888008-E19DC93D-B765-4EEE-99C0-02A4FB455E37Q36416038-5B9DD181-686E-44B1-8D60-82ECFB2EF534Q36752500-505B7F35-DD24-494C-8B1F-2A5A5A529C5CQ36758372-B4AF49CD-DB74-44DD-9ED5-736149AB6CD8Q37583864-AD40EF11-5673-407C-979B-0286B9F8D83CQ37599401-7687356A-BB77-4078-9C20-1DF3679C1E82Q38282980-D2CB09F8-93F3-40D4-BA63-6BCD24598F5BQ38365784-DD5F4F2F-7FFB-49A9-8937-5E35C1DAE949Q39101019-344A44C5-2510-4A19-BD68-972E945CC711Q39102878-D1782B9C-AA0A-4975-A1F2-1B703E1BBC1AQ41306366-D5AD5815-DE3C-43D0-A4B1-EEB0DD2BFC55Q41816216-F031B412-6687-4452-9913-69ED851ED949Q42036101-E8C59C85-A563-4363-81E7-ABD0EDC094D4Q42053464-3501140A-BCD1-46E6-AF41-8605B5A8EF7DQ42167682-EFBD7F91-9392-4C6B-A591-869D4BF0F474Q42284995-6F6AB0E9-0713-4C76-81A4-9418F46E1DFDQ42285172-28CB48D7-CACD-4E18-84EC-EF7573F140F1Q43222817-93D3C170-5FA0-4198-AF3C-5521652AC4A5Q58830766-9C62F165-2A21-40D4-B51D-0D76803BA1E8
P2860
The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist
@ast
The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist
@en
type
label
The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist
@ast
The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist
@en
prefLabel
The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist
@ast
The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist
@en
P2860
P1476
The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1982.TB09309.X
P407
P577
1982-10-01T00:00:00Z